Slingshot members are tracking this event:
Intercept Pharmaceuticals (ICPT) plans to commence Phase 2 INT-767 trial in the second half of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
|ICPT||Community voting in process|
Slingshot Insights Explained
Apr 17, 2018
Don’t see a project related to the catalyst you care about?
Related Keywords Int-767, Phase 2